Literature DB >> 31455163

Thickness of the airway surface liquid layer in the lung is affected in cystic fibrosis by compromised synergistic regulation of the ENaC ion channel.

Daniel V Olivença1, Luis L Fonseca2, Eberhard O Voit2, Francisco R Pinto1.   

Abstract

The lung epithelium is lined with a layer of airway surface liquid (ASL) that is crucial for healthy lung function. ASL thickness is controlled by two ion channels: epithelium sodium channel (ENaC) and cystic fibrosis (CF) transmembrane conductance regulator (CFTR). Here, we present a minimal mathematical model of ENaC, CFTR and ASL regulation that sheds light on the control of ENaC by the short palate lung and nasal epithelial clone 1 (SPLUNC1) protein and by phosphatidylinositol 4,5-biphosphate (PI(4,5)P2). The model, despite its simplicity, yields a good fit to experimental observations and is an effective tool for exploring the interplay between ENaC, CFTR and ASL. Steady-state data and dynamic information constrain the model's parameters without ambiguities. Testing the hypothesis that PI(4,5)P2 protects ENaC from ubiquitination suggests that this protection does not improve the model results and that the control of the ENaC opening probability by PI(4,5)P2 is sufficient to explain all available data. The model analysis further demonstrates that ASL at the steady state is sensitive to small changes in PI(4,5)P2 abundance, particularly in CF conditions, which suggests that manipulation of phosphoinositide metabolism may promote therapeutic benefits for CF patients.

Entities:  

Keywords:  airway surface liquid; cystic fibrosis; mathematical model; phosphoinositides

Year:  2019        PMID: 31455163      PMCID: PMC6731490          DOI: 10.1098/rsif.2019.0187

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  66 in total

Review 1.  Trafficking and cell surface stability of ENaC.

Authors:  D Rotin; V Kanelis; L Schild
Journal:  Am J Physiol Renal Physiol       Date:  2001-09

2.  ENaC-CFTR interactions: the role of electrical coupling of ion fluxes explored in an epithelial cell model.

Authors:  Jean-Daniel Horisberger
Journal:  Pflugers Arch       Date:  2002-12-04       Impact factor: 3.657

3.  Phosphatidylinositol 4,5-bisphosphate (PIP2) stimulates epithelial sodium channel activity in A6 cells.

Authors:  Gang Yue; Bela Malik; Guichin Yue; Douglas C Eaton
Journal:  J Biol Chem       Date:  2002-01-25       Impact factor: 5.157

4.  Airways in cystic fibrosis are acidified: detection by exhaled breath condensate.

Authors:  S Tate; G MacGregor; M Davis; J A Innes; A P Greening
Journal:  Thorax       Date:  2002-11       Impact factor: 9.139

5.  Activation of the epithelial Na+ channel (ENaC) requires CFTR Cl- channel function.

Authors:  M M Reddy; M J Light; P M Quinton
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

6.  CFTR-mediated inhibition of epithelial Na+ conductance in human colon is defective in cystic fibrosis.

Authors:  M Mall; M Bleich; J Kuehr; M Brandis; R Greger; K Kunzelmann
Journal:  Am J Physiol       Date:  1999-09

7.  Airway surface pH in subjects with cystic fibrosis.

Authors:  D McShane; J C Davies; M G Davies; A Bush; D M Geddes; E W F W Alton
Journal:  Eur Respir J       Date:  2003-01       Impact factor: 16.671

8.  Kinetic analysis of receptor-activated phosphoinositide turnover.

Authors:  Chang Xu; James Watras; Leslie M Loew
Journal:  J Cell Biol       Date:  2003-05-26       Impact factor: 10.539

Review 9.  Hormonal regulation of the epithelial sodium channel ENaC: N or P(o)?

Authors:  Bernard C Rossier
Journal:  J Gen Physiol       Date:  2002-07       Impact factor: 4.086

10.  cAMP increases density of ENaC subunits in the apical membrane of MDCK cells in direct proportion to amiloride-sensitive Na(+) transport.

Authors:  Ryan G Morris; James A Schafer
Journal:  J Gen Physiol       Date:  2002-07       Impact factor: 4.086

View more
  5 in total

Review 1.  Hyperinflammation and airway surface liquid dehydration in cystic fibrosis: purinergic system as therapeutic target.

Authors:  Thiago Inácio Teixeira do Carmo; Victor Emanuel Miranda Soares; Jonatha Wruck; Fernanda Dos Anjos; Débora Tavares de Resende E Silva; Sarah Franco Vieira de Oliveira Maciel; Margarete Dulce Bagatini
Journal:  Inflamm Res       Date:  2021-04-27       Impact factor: 4.575

2.  ENaC regulation by phospholipids and DGK explained through mathematical modeling.

Authors:  Daniel V Olivença; Eberhard O Voit; Francisco R Pinto
Journal:  Sci Rep       Date:  2020-08-18       Impact factor: 4.379

3.  Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach.

Authors:  Michela Abrami; Massimo Maschio; Massimo Conese; Marco Confalonieri; Francesco Salton; Fabio Gerin; Barbara Dapas; Rossella Farra; Alessandra Adrover; Gesmi Milcovich; Claudia Fornasier; Alice Biasin; Mario Grassi; Gabriele Grassi
Journal:  Drug Deliv Transl Res       Date:  2022-03-14       Impact factor: 5.671

4.  Modulator Combination Improves In Vitro the Microrheological Properties of the Airway Surface Liquid of Cystic Fibrosis Airway Epithelia.

Authors:  Alessandra Ludovico; Oscar Moran; Debora Baroni
Journal:  Int J Mol Sci       Date:  2022-09-27       Impact factor: 6.208

Review 5.  Is the ENaC Dysregulation in CF an Effect of Protein-Lipid Interaction in the Membranes?

Authors:  Birgitta Strandvik
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.